The Global Implantable Pulse Generator Market size is forecast to grow from $2.3 billion in 2018 to $4.6 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period. The growth can be attributed to factors such as advancements in technology and an increasing geriatric population base which has led to an increased number of patients suffering from chronic diseases, thereby driving demand for implantable pulse generators worldwide.
An Implantable Pulse Generator is a device that generates electrical pulses to help cardiac rhythm management. It can be used in the treatment of various heart conditions, although it is typically implanted as an accessory device for patients with bradyarrhythmias and tachycardia. Implantable pulse generators are surgically implanted into a patient's chest through minimally invasive or open-chest surgery, which then delivers high voltage electric impulses to specific parts of the heart muscle when necessary.
On the basis of Types, the market is segmented into Neurovascular Diseases, Cardiovascular Diseases, and Orthopedic Diseases.
Neurovascular diseases are an umbrella term for a range of conditions that affect the arteries or veins in the brain. These include strokes, cerebral hemorrhages, and other types of vascular accidents. Neurovascular events can lead to many different impairments depending on what has been damaged by the event itself; this may be physical (loss of motor function), cognitive (memory loss) or emotional problems as well as psychological difficulties such as anxiety disorders and depression. The most debilitating consequences arise when there is damage to both sides of the body due to neurodegenerative illness like multiple sclerosis which leads to paralysis, chronic pain, and severe disability.
Cardiovascular Disease is a type of disease that impacts the heart and blood vessels. The most common cardiovascular diseases are hypertension, coronary artery disease, congestive heart failure, angina (chest pain due to lack of oxygen-rich blood), myocardial infarction, or stroke.
Orthopedic Diseases are diseases involving the bones and joints. They can range from conditions such as achondroplasia, in which an individual has limbs that grow disproportionately to their body, or spina bifida, where part of the spinal cord sticks out through the skin around it.
On the basis of Application, the market is segmented into Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Clinics. In hospital settings, the implantable pulse generator is used to control and regulate blood pressure. It can also be used for other purposes such as treating arrhythmia, or irregular heart rhythms. For example, a pacemaker ensures that one's heartbeats in an even rhythm at all times by sending electrical pulses of electricity into the lower chambers of your heart (ventricles).
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North American market is anticipated to dominate the Implantable Pulse Generator Market throughout the forecast period. The market is driven mainly by demographic factors which include the increasing geriatric population in North America, and various initiatives being taken up by government agencies for improving healthcare services in this region.
The Asia Pacific market is projected to grow at positive growth in terms of value and volume throughout the forecast period. Factors driving this market include a rise in the prevalence rate for chronic diseases, such as diabetes, cardiovascular disease (CVD), obesity, hypertension among others.
The Latin American Implantable Pulse Generator Market is anticipated to register moderate growth rates during the forecast period owing to factors such as rising healthcare expenditure and increasing incidence of chronic illnesses.
The global implantable pulse generator market is subject to the growth factors such as an increasingly aging population, technological developments, and advancements in healthcare treatments. The increase in the number of patients who are living with chronic diseases coupled with a substantial rise in adoption rates for new drug therapies and medical devices has led to higher demand for implantable generators that produce electrical pulses.
Moreover, improvements in surgical techniques have enabled physicians to conduct more complex procedures without having to resort towards open heart surgeries especially when it comes to treating cardiovascular ailments or orthopedic disorders, etc. which will lead to increased utilization of IMD's by surgeons worldwide during their treatment regimen.
Up Market Research published a new report titled “Implantable Pulse Generator Market research report which is segmented by Types (Neurovascular Diseases, Cardiovascular Diseases, Orthopedic), By Applications (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics), By Players/Companies Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neurosigma, Neuropace, Cyberonics, BioControl Medical”.
|Report Attributes||Report Details|
|Report Title||Implantable Pulse Generator Market Research Report|
|By Type||Neurovascular Diseases, Cardiovascular Diseases, Orthopedic|
|By Application||Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics|
|By Companies||Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neurosigma, Neuropace, Cyberonics, BioControl Medical|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||200|
|Number of Tables & Figures||140|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Neurovascular Diseases, Cardiovascular Diseases, Orthopedic and By Application Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics.
Some of the companies that are profiled in this report are:
Implantable Pulse Generator Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Implantable Pulse Generator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Implantable Pulse Generator Market Report:
Some other reports from this category!